GUIDANT-CARDIAC PACEMAKERS
TaiwanUnited States6 products registeredMar 07, 1981 – May 31, 1999
VerifiedTFDA · Taiwan Food and Drug Administration registry
6
Total products
4
Product types
0
Active products
May 1999
Latest registration
Company details
- Address
- 4100 HAMLINE AVENUE NORTH ST. PAUL MN 55112 U.S.A.
Regulatory footprint
Search GUIDANT-CARDIAC PACEMAKERS across other regulatory registries
Recent registrations
Latest 5 products registered by this manufacturer
Most popular products
Products with most registrations
Authorized representatives
Taiwan authorized representatives for this manufacturer
Recent registered products
Most recent products (showing top 20)
Punk implantable heart rhythm rectifier defibrillator
Registered: May 31, 1999 • Expires: Apr 21, 2010
Cancelled
- AR
- Xiongqun Enterprise Limited
conducting wire
Registered: May 17, 1999 • Expires: Apr 21, 2010
Cancelled
- AR
- Xiongqun Enterprise Limited
Implanted cardiac rectifier
Registered: Dec 09, 1998 • Expires: Apr 21, 2010
Cancelled
- AR
- Xiongqun Enterprise Limited
Implanted cardiac rectifier
Registered: Mar 02, 1995 • Expires: Apr 21, 2010
Cancelled
- AR
- Xiongqun Enterprise Limited
Implanted cardiac rectifier
Registered: Mar 07, 1981 • Expires: Jun 15, 1999
Cancelled
- AR
- HSIN CHANG COMPANY LTD.
Patient ECG receiver
Registered: Mar 07, 1981 • Expires: Sep 09, 1985
Cancelled
- AR
- HSIN CHANG COMPANY LTD.
About this profile
Explore comprehensive manufacturer profile for GUIDANT-CARDIAC PACEMAKERS based in United States through Pure Global AI's free Taiwan medical device database. This manufacturer has 6 products registered in Taiwan across 4 unique product categories. Their regulatory history spans from Mar 07, 1981 to May 31, 1999.
This page provides detailed insights including 5 recent product registrations, 4 most popular products with Implanted cardiac rectifier having 3 registrations, and 2 authorized representatives including Xiongqun Enterprise Limited. Pure Global AI offers free access to Taiwan's medical device database, enabling global MedTech companies to analyze market dynamics and identify opportunities.